![Discuss the pathogenesis and imaging approach of](http://s1.studyres.com/store/data/004610016_1-552099995e0e86f066383a1739c4f94e-300x300.png)
Discuss the pathogenesis and imaging approach of
... • Somatotroph cell adenomas may be quite large by the time they come to clinical attention because the manifestations of excessive GH may be subtle ...
... • Somatotroph cell adenomas may be quite large by the time they come to clinical attention because the manifestations of excessive GH may be subtle ...
The choice of systemic adjuvant therapy in receptor
... the last 20 years, luteinising-hormone-releasing-hormone (LHRH) analogues have frequently substituted surgical or radiotherapy-induced ablation because of their ease of administration and the reversibility of their effects. Cytotoxic chemotherapy represents a fourth form of ovarian function suppressi ...
... the last 20 years, luteinising-hormone-releasing-hormone (LHRH) analogues have frequently substituted surgical or radiotherapy-induced ablation because of their ease of administration and the reversibility of their effects. Cytotoxic chemotherapy represents a fourth form of ovarian function suppressi ...
A clinical approach to gynecomastia
... early stage of the disease (within a year) where there is predominant inflammation and less fibrosis. Several medications can be used to modify hormonal changes involved in gynecomastia. Anti-estrogens, aromatase inhibitors and androgens are the available options. However the data on efficacy and sa ...
... early stage of the disease (within a year) where there is predominant inflammation and less fibrosis. Several medications can be used to modify hormonal changes involved in gynecomastia. Anti-estrogens, aromatase inhibitors and androgens are the available options. However the data on efficacy and sa ...
PITUITARY HORMONES AND THEIR HYPOTHALAMIC
... - Prostate cancer (to decrease testosterone production; prostate cancer is androgen-dependent) - Breast cancer (to decrease estradiol production; breast cancer may be estrogen-dependent) 3. Sex steroid responsive other conditions: Uterine disorders (endometriosis, uterine leiomyomas); acute intermit ...
... - Prostate cancer (to decrease testosterone production; prostate cancer is androgen-dependent) - Breast cancer (to decrease estradiol production; breast cancer may be estrogen-dependent) 3. Sex steroid responsive other conditions: Uterine disorders (endometriosis, uterine leiomyomas); acute intermit ...
Bioidentical Hormones
... In another investigation, these same researchers found a 40% increased risk of breast cancer for women who used estrogen with non-bioidentical progestin. Interestingly, women who used estrogen combined with bioidentical progesterone had a 10% reduced risk of breast cancer, compared to women who had ...
... In another investigation, these same researchers found a 40% increased risk of breast cancer for women who used estrogen with non-bioidentical progestin. Interestingly, women who used estrogen combined with bioidentical progesterone had a 10% reduced risk of breast cancer, compared to women who had ...
Epidemiology of Male Breast Cancer
... methods used for mutation screening are not completely sensitive; thus, some aberrations, such as noncoding mutations, could have been missed (9); (b) a positive family history of breast cancer may include sporadic FBCs due to the high prevalence of such cancers in the general population (9); (c) th ...
... methods used for mutation screening are not completely sensitive; thus, some aberrations, such as noncoding mutations, could have been missed (9); (b) a positive family history of breast cancer may include sporadic FBCs due to the high prevalence of such cancers in the general population (9); (c) th ...
Bioidentical Hormones - W Clinic of Integrative Medicine
... In another investigation, these same researchers found a 40% increased risk of breast cancer for women who used estrogen with non-bioidentical progestin. Interestingly, women who used estrogen combined with bioidentical progesterone had a 10% reduced risk of breast cancer, compared to women who had ...
... In another investigation, these same researchers found a 40% increased risk of breast cancer for women who used estrogen with non-bioidentical progestin. Interestingly, women who used estrogen combined with bioidentical progesterone had a 10% reduced risk of breast cancer, compared to women who had ...
It`s All About Balance - Women`s International Pharmacy
... Human growth hormone (hGH) is another hormone that is present in large quantities in our body when we are young, peaks in our mid-20s, but tends to disappear as we age. The primary function of hGH in our youth is to help bones lengthen and expand to help us become taller, stronger-boned, and longlim ...
... Human growth hormone (hGH) is another hormone that is present in large quantities in our body when we are young, peaks in our mid-20s, but tends to disappear as we age. The primary function of hGH in our youth is to help bones lengthen and expand to help us become taller, stronger-boned, and longlim ...
Hormonal Regulation of Calcium Signaling in
... 1,25(OH)2D. In most of other endocrine cancers the changes in calcium homeostasis with respect to PTH, 1,25(OH)2D and calcitonin is well studied. The main focus of this review is how hormones can regulate calcium homeostasis in endocrine cancers. Role of Pth-dependent Calcium Homeostasis in Differen ...
... 1,25(OH)2D. In most of other endocrine cancers the changes in calcium homeostasis with respect to PTH, 1,25(OH)2D and calcitonin is well studied. The main focus of this review is how hormones can regulate calcium homeostasis in endocrine cancers. Role of Pth-dependent Calcium Homeostasis in Differen ...
T Is Systemic Anti‑Cancer Therapy Neurotoxic? Does ‘Chemobrain’ Exist?
... in the absence of recurrence of disease and their levels are not higher in patients who had received chemotherapy.40 Cytokine levels might relate to deficits in cognitive function. As mentioned by Miller et al, many factors may trigger the activation of inflammatory pathways in cancer patients, “suc ...
... in the absence of recurrence of disease and their levels are not higher in patients who had received chemotherapy.40 Cytokine levels might relate to deficits in cognitive function. As mentioned by Miller et al, many factors may trigger the activation of inflammatory pathways in cancer patients, “suc ...
Menopause - UNC School of Medicine
... GU atrophy Bladder irritability, vaginal dryness, dyspareunia ...
... GU atrophy Bladder irritability, vaginal dryness, dyspareunia ...
the sexual wellbeing and breast cancer in Australia
... The Impact of Breast Cancer on Sexual Wellbeing 1956 participants reported changes in sexual wellbeing, described as decreases in: feeling desirable (73%, 1385), intimacy (60%, 1090), frequency of sex (78%, 1427), sexual arousal (74%, 1344), sexual pleasure (64%, 1151), satisfaction with sex (62%, 1 ...
... The Impact of Breast Cancer on Sexual Wellbeing 1956 participants reported changes in sexual wellbeing, described as decreases in: feeling desirable (73%, 1385), intimacy (60%, 1090), frequency of sex (78%, 1427), sexual arousal (74%, 1344), sexual pleasure (64%, 1151), satisfaction with sex (62%, 1 ...
Anterior Segment Findings in Women with Polycystic Ovary Syndrome
... Objectives: This study aimed to investigate the anterior segment in women with polycystic ovary syndrome (PCOS) and to compare them with those of healthy reproductive-age female volunteers. Materials and Methods: The study included 50 right eyes of 50 women with PCOS (group 1) and 50 right eyes of 5 ...
... Objectives: This study aimed to investigate the anterior segment in women with polycystic ovary syndrome (PCOS) and to compare them with those of healthy reproductive-age female volunteers. Materials and Methods: The study included 50 right eyes of 50 women with PCOS (group 1) and 50 right eyes of 5 ...
Thyroid Tests
... Average dose 1.6 ug/kg Age > 50-60 or cardiac disease: must start at a low dose (25 ug/d) Recheck thyroid hormone levels every 4-6 weeks after a dose change Aim for a normal TSH level ...
... Average dose 1.6 ug/kg Age > 50-60 or cardiac disease: must start at a low dose (25 ug/d) Recheck thyroid hormone levels every 4-6 weeks after a dose change Aim for a normal TSH level ...
Sex after breast cancer: a forgotten burden
... women receiving E2 tablets or E3 cream at low dose, without difference between the two preparations. A further improvement was seen at the end of 3 months of therapy. In women receiving vaginal moisturizer, although a transient benefit on symptoms related to vaginal atrophy was recorded after 4 weeks ...
... women receiving E2 tablets or E3 cream at low dose, without difference between the two preparations. A further improvement was seen at the end of 3 months of therapy. In women receiving vaginal moisturizer, although a transient benefit on symptoms related to vaginal atrophy was recorded after 4 weeks ...
Women`s Health Updates: Hormone Therapy
... combination estrogen/progestin medication called Prempro faced a slightly increased risk of breast cancer, heart disease, stroke and blood clots. The risks prompted the U.S. Food and Drug Administration (FDA) to mandate warning labels on all estrogen products advising women to use the least amount o ...
... combination estrogen/progestin medication called Prempro faced a slightly increased risk of breast cancer, heart disease, stroke and blood clots. The risks prompted the U.S. Food and Drug Administration (FDA) to mandate warning labels on all estrogen products advising women to use the least amount o ...
A Majority of Low (1-10%) ER Positive Breast
... leads to the false categorization of biologically ER negative tumors as ER positive ones. This may have particular relevance to India, where we have a much higher proportion of ER negative tumors in general. Key words: ER 1-10 %, gene expression, q-RT-PCR, FFPE, Breast Cancer ...
... leads to the false categorization of biologically ER negative tumors as ER positive ones. This may have particular relevance to India, where we have a much higher proportion of ER negative tumors in general. Key words: ER 1-10 %, gene expression, q-RT-PCR, FFPE, Breast Cancer ...
Premature Ovarian Failure (POF)
... fasting insulin, ↑ prolactin, ↑oestradiol, ↑ oestrone, ↓ sex hormone binding globulin. Possible late sequelae: D.M., dyslipidaemia, hypertension, cardiovascular disease, endometrial carcinoma. Management: the clinical management of a woman with PCOS should be focused on her individual problems. So o ...
... fasting insulin, ↑ prolactin, ↑oestradiol, ↑ oestrone, ↓ sex hormone binding globulin. Possible late sequelae: D.M., dyslipidaemia, hypertension, cardiovascular disease, endometrial carcinoma. Management: the clinical management of a woman with PCOS should be focused on her individual problems. So o ...
Letrozole Significantly Improves Growth Potential in a Pubertal Boy
... The effect of estrogen on the dynamic processes of bone turnover is multifactorial. Its actions involve other hormones and factors such as GH, IGFs and their binding proteins, other growth and morphogenic factors, thyroid hormone, vitamin D, retinoids, PTH and PTH-related peptide, cytokines, and the ...
... The effect of estrogen on the dynamic processes of bone turnover is multifactorial. Its actions involve other hormones and factors such as GH, IGFs and their binding proteins, other growth and morphogenic factors, thyroid hormone, vitamin D, retinoids, PTH and PTH-related peptide, cytokines, and the ...
Estrogen Receptors: Structure, Mechanisms and Function
... (Fig. 2). First, ER can regulate expression of genes that lack EREs. One such mechanism that has been studied in some detail is the ER regulation of genes containing AP1 elements that bind the fos/jun dimer, which recruits ERa and co-activators [16]. In addition, ER may also sequester repressors awa ...
... (Fig. 2). First, ER can regulate expression of genes that lack EREs. One such mechanism that has been studied in some detail is the ER regulation of genes containing AP1 elements that bind the fos/jun dimer, which recruits ERa and co-activators [16]. In addition, ER may also sequester repressors awa ...
IGF-1 in the Brain as a Regulator of Reproductive
... The major source of peripheral IGF-1 is the liver, where its production is induced by GH (43). In addition, other organs of the body, including the lung, kidney, thymus, spleen, heart, muscle, stomach, and gonads can produce IGF-1 (3–5). In fact, a transgenic mouse with the IGF-1 gene knocked out sp ...
... The major source of peripheral IGF-1 is the liver, where its production is induced by GH (43). In addition, other organs of the body, including the lung, kidney, thymus, spleen, heart, muscle, stomach, and gonads can produce IGF-1 (3–5). In fact, a transgenic mouse with the IGF-1 gene knocked out sp ...
Guidelines for Ordering Serum Levels of Gonadotropins (FSH, LH
... FSH and LH (gonadotropins) are produced by the pituitary gland. They (especially LH) are released in a pulsatile fashion in response to the pulsatile secretion of hypothalamic gonadotropin‐releasing hormone (GnRH). In women, the pulse frequency (generally occurring as often as every 60‐90 minutes, b ...
... FSH and LH (gonadotropins) are produced by the pituitary gland. They (especially LH) are released in a pulsatile fashion in response to the pulsatile secretion of hypothalamic gonadotropin‐releasing hormone (GnRH). In women, the pulse frequency (generally occurring as often as every 60‐90 minutes, b ...
Adherence to WCRF/AICR Cancer Prevention Recommendations
... Research (AICR) released eight recommendations related to body fatness, physical activity, and diet aimed at preventing the most common cancers worldwide. However, limited information exists on the association between meeting these recommendations and risks of specific cancers, including breast canc ...
... Research (AICR) released eight recommendations related to body fatness, physical activity, and diet aimed at preventing the most common cancers worldwide. However, limited information exists on the association between meeting these recommendations and risks of specific cancers, including breast canc ...
Female Reproductive System
... treating diseases/disorders of the female reproductive system. Obstetrician - MD that specializes in providing medical care to women during pregnancy, childbirth, and immediately after birth. ...
... treating diseases/disorders of the female reproductive system. Obstetrician - MD that specializes in providing medical care to women during pregnancy, childbirth, and immediately after birth. ...